Wedbush Reiterates Outperform on Generation Bio, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten reiterates an Outperform rating on Generation Bio (NASDAQ:GBIO) and maintains a $5 price target.
March 07, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst David Nierengarten reiterates an Outperform rating on Generation Bio and maintains a $5 price target.
The reiteration of an Outperform rating by a reputable analyst, along with the maintenance of a $5 price target, suggests a positive outlook on GBIO's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100